Conolidine’s analgesic outcomes stem from its conversation with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors from the central anxious program, conolidine modulates alternate molecular targets. A Science Improvements analyze observed that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, whic… Read More